5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) Versus Epirubicin, Cisplatin and 5-FU (ECF) in Patients With Locally Advanced, Resectable Gastric Cancer
This study is currently recruiting participants.
Verified August 2012 by Krankenhaus Nordwest
Study NCT01216644
Information provided by Krankenhaus Nordwest
First Received on June 30, 2010.
Last Updated on August 15, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
